Olivier Mir, MD, PhD, MPH is a medical oncologist and clinical pharmacologist in Gustave Roussy Cancer Institute, University of Paris-Sud. Dr. Mir trained as a medical oncologist and clinical pharmacologist at University Paris Descartes, and obtained the Silver medal (highest degree) from Paris Medical School in 2009. Dr. Mir is currently member of Breast and Sarcoma Groups at Gustave Roussy Cancer Institute in Paris, and is an active member of the French Sarcoma Group (GSF-GETO), Francilian Onco-Geriatry Group (FROG), EORTC Soft Tissue and Bone Sarcoma Group, and French Group on “Cancer in pregnancy” (CALG). His main research interests are: sarcoma/GIST, anti-VEGF agents, early drug development, pregnancy-related neoplasms, and geriatric oncology. He is also involved in translational research aspects related to precision medicine and pharmacokinetics notably in sarcoma/GIST, and pregnancy-related neoplasms (INSERM unit CIC-P 0901, Prof JM Treluyer, Paris Descartes University). Dr. Mir has contributed to over 100 peer-reviewed medical publications.